Filing Details

Accession Number:
0001562180-17-002676
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-14 20:56:20
Reporting Period:
2017-08-10
Filing Date:
2017-08-14
Accepted Time:
2017-08-14 20:56:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1557883 Dermira Inc. DERM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1014095 B Fred Craves C/O Dermira, Inc.
275 Middlefield Road, Suite 150
Menlo Park CA 94025
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-10 20,000 $22.57 20,000 No 4 P Indirect Fred Craves Family Foundation
Common Stock Acquisiton 2017-08-14 10,000 $23.95 30,000 No 4 P Indirect Fred Craves Family Foundation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Fred Craves Family Foundation
No 4 P Indirect Fred Craves Family Foundation
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,441,075 Indirect See footnote
Common Stock 65,572 Indirect See footnote
Footnotes
  1. Dr. Craves serves as the chief executive officer of the Fred Craves Family Foundation (the "Foundation"). Dr. Craves does not have a pecuniary interest in the shares held by the Foundation and disclaims beneficial ownership over such shares. This report shall not be deemed an admission that the reporting person is the beneficial owner of such shares.
  2. The securities are held directly by Bay City Capital Fund V, L.P. ("Fund V"). Dr. Craves disclaims beneficial ownership over the securities owned by Fund V, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in Bay City Capital LLC, which is the manager of Fund V's general partner, Bay City Capital Management V LLC.
  3. The securities are held directly by Bay City Capital Fund V Co-Investment Fund, L.P. ("Co-Investment V"). Dr. Craves disclaims beneficial ownership over the securities owned by Co-Investment V, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in Bay City Capital LLC, which is the manager of Co-Investment V's general partner, Bay City Capital Management V LLC.